Drug recall · August 22, 2012
RANIBIZUMAB recall
Why: Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
RANIBIZUMAB, SDPF - (0.05ML SYRINGE, 31G, 5/16") 10MG/ML INJECTABLE 1 ML 1.25 ML 1.75 ML 2.3 ML 2.35 ML 20 ML 20.15 ML 20.45 ML 20.6 ML 20.9 ML 21.05 ML 21.2 ML 21.25 ML 21.45 ML 21.6 ML 21.7 ML 24.4 ML 28.1 ML (18 DIFFERENT PRODUCTS)
- Lots / codes
Rx #'s: 0397570 0397570 0397570 0397570 0397570 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846 0373846
- Quantity
- 19 units
- Company
- Franck's Lab Inc., d.b.a. Franck's Compounding Lab, Ocala, FL
- Distribution
- Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies
- Initiated
- May 21, 2012 · Voluntary: Firm initiated
- Classified
- August 10, 2012
- Reported
- August 22, 2012
- Ended
- August 15, 2014
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.